Bulletin
Investor Alert

New York Markets Open in:

Ipsen

PAR: FR:IPN

GO

IPN
/zigman2/quotes/200122335/delayed

98.95

Change

-1.15 -1.15%

Volume

Volume 26,186

Oct 6, 2022, 2:52 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/200122335/delayed

Previous close

100.10

98.95

Change

-1.15 -1.15%

Day low

Day high

€98.95

€101.00

Open
Open: 100.30

52 week low

52 week high

€77.00

€121.00

Open

Market cap

€8.24B

Average volume

75,735

P/E ratio

11.13

Rev. per Employee

€513,980

EPS

8.89

Dividend

1.20

Div yield

1.21%

Ex dividend date

5/31/22

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/fr/ipn

MarketWatch News on IPN

  1. Syndax Pharmaceuticals Gains 57% After Cancer Conference

    5:29 p.m. April 28, 2020

    - Barron's Online

  2. Stocks close higher as Trump delays China tariff deadline

    5:35 p.m. Feb. 25, 2019

    - Sue Chang

  3. Ipsen profit up; hemophilia-drug partnership set

    2:12 a.m. Aug. 30, 2011

    - Robert Daniel

  4. Roche disappoints as revamp costs weigh

    3:52 a.m. Feb. 2, 2011

    - Goran Mijuk

  5. Updates, advisories and surprises

    10:01 p.m. March 1, 2010

    - MarketWatch

  6. Ipsen '09 net rose 6.8% on 7.2% higher revenue

    2:49 a.m. March 1, 2010

    - Robert Daniel

  7. Pharmas help Europe stocks end losing run

    12:59 p.m. Jan. 26, 2010

    - Sarah Turner

  8. Novo Nordisk rallies as FDA clears diabetes drug

    7:44 a.m. Jan. 26, 2010

    - Steve Goldstein

  9. European shares edge higher; Vodafone rises

    1:13 p.m. Dec. 2, 2009

    - Sarah Turner

  10. Roche says new diabetes drug works better than Merck's Januvia

    3:59 a.m. Dec. 2, 2009

    - MarketWatch.com

  11. Ipsen sees upper-end FY revenue

    1:42 a.m. July 31, 2008

    - Steve Goldstein

  12. Roche moves Ipsen diabetes drug to Phase III trials

    2:10 a.m. June 10, 2008

    - Robert Daniel

  13. Updates, advisories and surprises

    5:01 p.m. Aug. 29, 2007

    - MarketWatch

  14. Ipsen profit falls on price cuts, taxes, end of Roche deal

    2:56 a.m. Aug. 29, 2007

    - Steve Goldstein

  15. Updates, advisories and surprises

    10:31 a.m. March 19, 2007

    - MarketWatch

  16. France's Ipsen '06 profit off 3%, revenue up 6.5%

    2:55 a.m. March 19, 2007

    - Robert Daniel

  17. Loading more headlines...
/news/nonmarketwatch/company/fr/ipn

Other News on IPN

  1. Big Pharma Won’t Bail Out Battered Biotech

    2:34 a.m. July 1, 2022

    - The Wall Street Journal Interactive Edition

  2. Ipsen up 4% on diminished generic threat to Somatuline

    11:56 a.m. Jan. 29, 2020

    - Seeking Alpha

  3. Roche Diabetes Drug Faces Delay

    8:34 a.m. June 18, 2010

    - The Wall Street Journal Interactive Edition

/news/pressrelease/company/fr/ipn

Press Releases on IPN

  1. SHAREHOLDER ALERT: Weiss Law Investigates Epizyme, Inc.

    4:57 p.m. June 27, 2022

    - PR Newswire - PRF

  2. Ipsen to acquire Epizyme, expanding its portfolio in oncology

    1:01 a.m. June 27, 2022

    - BusinessWire - BZX

  3. Ipsen to Acquire Epizyme, Expanding Its Portfolio in Oncology

    1:00 a.m. June 27, 2022

    - BusinessWire - BZX

  4. Ipsen Delivers a Strong Sales Performance in the First Quarter Of 2022

    12:57 a.m. April 27, 2022

    - BusinessWire - BZX

  5. Ipsen Nominates Karen Witts as New Independent Board Member

    2:00 a.m. Jan. 21, 2022

    - BusinessWire - BZX

  6. Loading more headlines...

Rates »

Link to MarketWatch's Slice.